GRIDS Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Atrandi Biosciencesatrandi.cominFeb 2025 · $25M
Atrandi builds single-cell analysis technology based on Semi-Permeable Capsules (SPCs) and droplet platforms, enabling multi-step, multi-omic workflows to be run on the same cell.
BiotechDeep TechHardware
Co-investorsMetaplanetPractica CapitalVsquared VenturesLux Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.